Royalty Pharma Plc (RPRX)
64.76
+0.90
(+1.41%)
USD |
NASDAQ |
Oct 26, 16:00
64.88
+0.12
(+0.19%)
After-Hours: 17:47
Royalty Pharma Price to Book Value : 4.225 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.166 |
| October 22, 2026 | 4.159 |
| October 21, 2026 | 4.054 |
| October 20, 2026 | 4.061 |
| October 19, 2026 | 3.932 |
| October 16, 2026 | 3.977 |
| October 15, 2026 | 3.889 |
| October 14, 2026 | 3.848 |
| October 13, 2026 | 3.690 |
| October 12, 2026 | 3.769 |
| October 09, 2026 | 3.714 |
| October 08, 2026 | 3.667 |
| October 07, 2026 | 3.703 |
| October 06, 2026 | 3.682 |
| October 05, 2026 | 3.696 |
| October 02, 2026 | 3.729 |
| October 01, 2026 | 3.760 |
| September 30, 2026 | 3.807 |
| September 29, 2026 | 3.798 |
| September 28, 2026 | 3.808 |
| September 25, 2026 | 3.797 |
| September 24, 2026 | 3.803 |
| September 23, 2026 | 3.761 |
| September 22, 2026 | 3.818 |
| September 21, 2026 | 3.812 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.810 |
| September 17, 2026 | 3.844 |
| September 16, 2026 | 3.814 |
| September 15, 2026 | 3.814 |
| September 14, 2026 | 3.852 |
| September 11, 2026 | 3.824 |
| September 10, 2026 | 3.833 |
| September 09, 2026 | 3.953 |
| September 08, 2026 | 3.953 |
| September 04, 2026 | 4.172 |
| September 03, 2026 | 4.167 |
| September 02, 2026 | 4.117 |
| September 01, 2026 | 4.066 |
| August 31, 2026 | 4.006 |
| August 28, 2026 | 3.970 |
| August 27, 2026 | 4.040 |
| August 26, 2026 | 4.032 |
| August 25, 2026 | 4.049 |
| August 24, 2026 | 4.001 |
| August 21, 2026 | 4.000 |
| August 20, 2026 | 3.952 |
| August 19, 2026 | 4.027 |
| August 18, 2026 | 3.894 |
| August 17, 2026 | 3.878 |
| August 14, 2026 | 3.823 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.277 |
| Johnson & Johnson | 7.868 |
| ANI Pharmaceuticals, Inc. | 2.767 |
| Corcept Therapeutics, Inc. | 13.34 |
| Veru, Inc. | 1.334 |
Price to Book Value Related Metrics
| PE Ratio | 34.48 |
| PS Ratio | 13.42 |
| Price to Free Cash Flow | 55.56 |
| Price | 64.76 |
| Earnings Yield | 2.90% |
| Market Cap | 28.87B |
| Operating PE Ratio | 21.53 |
| Normalized PE Ratio | 36.67 |